AHA is weighing in on drug shortages that impact patient care in response to a request by Republican leaders in the House and Senate. Rep. Cathy McMorris Rodgers, R-Wash., chair of the House Committee on Energy and Commerce, and Sen. Mike Crapo, R-Idaho, ranking member of the Senate Finance Committee, sought the information to better understand the issue. In its response, AHA described the wide range of shortages that impact patients suffering from a vast array of illnesses. AHA urged a number of actions, including strengthening the supply chain for prescription drugs, diversifying manufacturing sites and increasing end-user inventories, along with steps the Food and Drug Administration can take to further stabilize the nation’s supply of essential drugs. 

Related News Articles

Headline
In a statement submitted to the Senate Finance Committee Dec. 5 for a hearing on drug shortages and potential health policy solutions, AHA reiterated its…
Headline
The House Energy and Commerce Committee held a hearing on legislative proposals to prevent and respond to generic drug shortages. In comments submitted…
Headline
AHA recently voiced support for four bipartisan bills introduced in the Senate to help alleviate the nation’s chronic and growing drug shortages.   …
News
Pfizer will ship certain sterile injectable products directly to customers under an emergency ordering process implemented yesterday due to high demand for the…
Headline
The Food and Drug Administration said it did not expect “any immediate significant impacts on supply” after a tornado damaged a Pfizer plant in North…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…